Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Routine renal ultrasounds are standard during active enzyme replacement therapy (ERT) because kidney injury from lysosomal storage disorders such as Fabry disease can progress silently, even when bloodwork and symptoms appear stable. The scan is fast, radiation free, and non-invasive, allowing clinicians to track kidney size, cortical thickness, scarring, cysts, and possible obstruction alongside eGFR and urine protein trends. Serial imaging compared against a baseline also shows whether ERT is preserving kidney structure or whether dosing, adjunct therapy, or a nephrology referral should be reconsidered. Timing, frequency, and what counts as a meaningful change depend on several factors, and those details are explained below.
If you are on ERT and noticing swelling, changes in urination, fatigue, or blood pressure shifts, a free, instant, online symptom check can help you organize what you are experiencing, understand which findings warrant urgent att
Enzyme replacement therapy (ERT) with Strensiq® (asfotase alfa) has transformed care for people with hypophosphatasia (HPP), improving bone mineralization and quality of life. Alongside its benefits, active ERT can alter mineral balances in the body, potentially leading to kidney calcification. For this reason, kidney calcification monitoring via routine renal ultrasound has become standard protocol. Below, we explain why these scans are important, how often they’re recommended, and what you can expect.
Strensiq works by replacing deficient tissue-nonspecific alkaline phosphatase (TNSALP), a key enzyme for bone mineralization. As bone healing accelerates, calcium and phosphate levels in blood and urine can shift:
Without regular monitoring, these deposits can progress silently, compromising kidney function over time.
Renal ultrasound is a noninvasive, painless imaging test that uses sound waves to visualize kidney structure. It is ideal for kidney calcification monitoring because:
International guidelines and the Strensiq prescribing information recommend regular renal ultrasounds to catch kidney calcifications before they cause serious damage. A typical schedule may include:
Your healthcare team will tailor this schedule based on age, kidney function tests, and any prior imaging findings.
During a renal ultrasound, radiologists evaluate:
This information helps nephrologists and metabolic specialists decide if ERT dosage adjustments or additional interventions (e.g., hydration, dietary modifications) are needed.
Catching kidney calcifications early offers several advantages:
If your ultrasound shows any calcifications, your care team may:
Waiting for any medical test can be stressful. Here are a few pointers to make renal ultrasound smoother:
While renal ultrasound is key for kidney calcification monitoring, comprehensive care also includes:
Most mineral shifts on Strensiq are mild and reversible with early intervention. However, certain symptoms warrant prompt attention:
Speak to a doctor immediately if you experience these or any other life-threatening or serious symptoms.
It’s natural to have questions about new aches, pains, or changes during ERT. If you’re unsure whether something requires medical follow-up, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool can help you decide if you need to contact your healthcare team right away.
By staying proactive with routine renal ultrasound exams and open communication, you and your healthcare team can maximize the benefits of Strensiq while minimizing risks to your kidneys.
(References)
* Gucev ZS, Tasic V, Pop-Jordanova N, Kirovski I, Stomnaroska O, Martinova M, Jancevska A, Kremensky I, Sinigerska I. Type I Gaucher disease (GDI) in three siblings: enzyme replacement treatment (ERT) required. Prilozi. 2009 Jul;30(1):233-40. PMID: 19736544.
* Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Dahir KM, Nunes ME. Hypophosphatasia. 1993. PMID: 20301329.
* Nabhan ZM, Eugster EA. Medical care of girls with Turner Syndrome: where are we lacking? Endocr Pract. 2011 Sep-Oct;17(5):747-52. doi: 10.4158/EP11059.OR. PMID: 21454226.
* Freriks K, Timmermans J, Beerendonk CC, Verhaak CM, Netea-Maier RT, Otten BJ, Braat DD, Smeets DF, Kunst DH, Hermus AR, Timmers HJ. Standardized multidisciplinary evaluation yields significant previously undiagnosed morbidity in adult women with Turner syndrome. J Clin Endocrinol Metab. 2011 Sep;96(9):E1517-26. doi: 10.1210/jc.2011-0346. Epub 2011 Jul 13. PMID: 21752892.
* Pisani A, Petruzzelli Annicchiarico L, Pellegrino A, Bruzzese D, Feriozzi S, Imbriaco M, Tedeschi E, Cocozza S, De Rosa D, Mignani R, Veroux M, Battaglia Y, Concolino D, Sestito S, Pieruzzi F, Caroti L, Manna R, Zizzo C, Santangelo M, Sabbatini M, Riccio E. Parapelvic cysts, a distinguishing feature of renal Fabry disease. Nephrol Dial Transplant. 2018 Feb 1;33(2):318-323. doi: 10.1093/ndt/gfx009. PMID: 28371803.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.